skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

140-OR: Projected Impact of the Medicare Part D Senior Savings Model (SSM) on Diabetes-Related Health and Economic Outcomes among Insulin Users Covered by Medicare

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1) [Peer Reviewed Journal]

Copyright American Diabetes Association Jun 1, 2021 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db21-140-OR

Full text available

  • Title:
    140-OR: Projected Impact of the Medicare Part D Senior Savings Model (SSM) on Diabetes-Related Health and Economic Outcomes among Insulin Users Covered by Medicare
  • Author: SHAO, HUI ; KIANMEHR, HAMED ; SHI, LIZHENG ; FONSECA, VIVIAN ; BROWN, JOSHUA D.
  • Subjects: Clinical outcomes ; Cost control ; Diabetes ; Diabetes mellitus ; Insulin ; Medicare
  • Is Part Of: Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)
  • Description: CMS announced the Medicare Part D SSM to lower out-of-pocket costs for insulin. This study aimed to estimate the impacts of the SSM on clinical and economic outcomes among Medicare insulin users. We used the 2015-2016 National Health and Nutrition Examination Survey to generate a nationally representative simulation sample. We used the Building, Relating, Validating, Assessing, Outcomes (BRAVO™) Diabetes microsimulation model to simulate the impact of the SSM on diabetes-related complications, quality-adjusted life-years (QALYs), and medical costs. We used 30% rebate rate for Medicare insulin payment. 1.29 million insulin users covered by Medicare enhanced health plans are projected to be eligible for SSM in 2021. The SSM associated risk reductions in complications were reported in the Table. Over 5 years, the SSM is projected to increase $2.0 billion medical cost ($1,573/person) with a gain of 7,750 (0.01/person) QALYs (Incremental cost-effectiveness ratio (ICER): $157,300/QALY). In 20 years, the SSM will incur an additional $4.5 billion medical cost ($3474/person) with an increased QALYs of 72,095 (0.06/person, ICER=$57,900/QALY). Because the SSM was projected to increase medical costs for diabetes, this policy would have to be in place for longer than the 5-year period (as currently planned), or further reduce Medicare payment on insulin.
  • Publisher: New York: American Diabetes Association
  • Language: English
  • Identifier: ISSN: 0012-1797
    EISSN: 1939-327X
    DOI: 10.2337/db21-140-OR
  • Source: Alma/SFX Local Collection
    NCBI PubMed Central（免费）
Back to results list
Go to Previous pagePrevious Result  86 NextGo to Next page
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait